BofA Securities Reiterates Neutral Rating on UnitedHealth Group (UNH), Keeps PT

On June 3, BofA Securities analysts reiterated a ‘Neutral’ rating and a $350 price target on UnitedHealth Group Incorporated (NYSE:UNH) stock. The neutral stance follows the company’s announcement that it will release an updated 2025 guidance with its Q2 results on July 29.

BofA Securities Reiterates Neutral Rating and $350 Price Target on UnitedHealth Group (UNH)

A healthcare professional wearing a health communications device discussing patient data with a colleague.

UnitedHealth Group typically reports its Q2 results on July 14. Delaying the same by two weeks raises serious concerns about the quarterly results. The company’s CEO has already hinted at significant pressure within the commercial book business. This comes after Elevance raised concerns about ACA exchanges and Medicaid.

BofA Securities analysts still have a Neutral rating for UnitedHealth due to worries about Medicare Advantage and its valuation. They currently favor post-acute care providers and see Encompass Health (NYSE:EHC) as a top pick. Analysts think that if managed care companies face issues, it might be good news for healthcare providers.

UnitedHealth Group is a healthcare company that offers consumer-oriented health benefit plans. It also provides care delivery, care management, wellness and consumer engagement, and health financial services.

While we acknowledge the potential of UnitedHealth Group (NYSE:UNH) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None.